Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by MetLife Investment Management LLC

MetLife Investment Management LLC reduced its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.4% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 108,302 shares of the medical equipment provider’s stock after selling 2,675 shares during the quarter. MetLife Investment Management LLC’s holdings in Intuitive Surgical were worth $53,206,000 as of its most recent SEC filing.

A number of other hedge funds have also made changes to their positions in the stock. Hazlett Burt & Watson Inc. lifted its stake in Intuitive Surgical by 5.8% during the third quarter. Hazlett Burt & Watson Inc. now owns 362 shares of the medical equipment provider’s stock valued at $177,000 after purchasing an additional 20 shares during the last quarter. Mitchell Mcleod Pugh & Williams Inc. grew its position in Intuitive Surgical by 4.1% in the third quarter. Mitchell Mcleod Pugh & Williams Inc. now owns 503 shares of the medical equipment provider’s stock worth $247,000 after buying an additional 20 shares during the last quarter. Ullmann Wealth Partners Group LLC lifted its position in shares of Intuitive Surgical by 1.6% during the 3rd quarter. Ullmann Wealth Partners Group LLC now owns 1,329 shares of the medical equipment provider’s stock valued at $653,000 after acquiring an additional 21 shares during the last quarter. Meeder Advisory Services Inc. boosted its stake in shares of Intuitive Surgical by 0.3% during the 3rd quarter. Meeder Advisory Services Inc. now owns 7,386 shares of the medical equipment provider’s stock worth $3,629,000 after acquiring an additional 22 shares in the last quarter. Finally, One Wealth Management Investment & Advisory Services LLC raised its position in shares of Intuitive Surgical by 3.4% during the second quarter. One Wealth Management Investment & Advisory Services LLC now owns 697 shares of the medical equipment provider’s stock worth $310,000 after purchasing an additional 23 shares during the period. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Price Performance

Shares of NASDAQ ISRG traded down $0.73 during trading hours on Wednesday, hitting $541.37. 38,018 shares of the stock were exchanged, compared to its average volume of 1,451,329. Intuitive Surgical, Inc. has a one year low of $304.50 and a one year high of $552.00. The company’s 50 day moving average is $506.81 and its 200 day moving average is $466.29. The firm has a market capitalization of $192.83 billion, a P/E ratio of 87.15, a P/E/G ratio of 5.28 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.24 by $0.32. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. The company had revenue of $2.04 billion during the quarter, compared to analysts’ expectations of $2.01 billion. Research analysts anticipate that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current fiscal year.

Insider Activity

In related news, EVP Robert Desantis sold 188 shares of the company’s stock in a transaction on Thursday, August 29th. The stock was sold at an average price of $482.21, for a total value of $90,655.48. Following the completion of the transaction, the executive vice president now directly owns 5,506 shares in the company, valued at approximately $2,655,048.26. This represents a 3.30 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Jamie Samath sold 22,903 shares of Intuitive Surgical stock in a transaction on Friday, November 8th. The stock was sold at an average price of $525.00, for a total transaction of $12,024,075.00. Following the sale, the insider now owns 8,757 shares in the company, valued at $4,597,425. This represents a 72.34 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders sold 50,647 shares of company stock valued at $26,170,907. 0.80% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

ISRG has been the subject of a number of recent analyst reports. Redburn Atlantic upgraded Intuitive Surgical from a “neutral” rating to a “buy” rating and increased their price target for the company from $380.00 to $510.00 in a research report on Friday, August 2nd. Citigroup lifted their target price on shares of Intuitive Surgical from $512.00 to $560.00 and gave the stock a “buy” rating in a research report on Thursday, August 22nd. Mizuho raised their price objective on shares of Intuitive Surgical from $440.00 to $500.00 in a research note on Thursday, October 17th. Royal Bank of Canada boosted their target price on shares of Intuitive Surgical from $525.00 to $555.00 and gave the company an “outperform” rating in a research note on Friday, October 18th. Finally, The Goldman Sachs Group set a $604.00 price target on Intuitive Surgical in a report on Friday, October 18th. One research analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have given a buy rating to the company’s stock. According to data from MarketBeat, Intuitive Surgical has a consensus rating of “Moderate Buy” and a consensus price target of $526.06.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.